RichardBZelmanMD
Cardiology • Forestdale, MAAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Are you Dr. Zelman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 99 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
83 Route 130
Forestdale, MA 02644Phone+1 508-827-1954Fax+1 508-827-8751
Summary
- Dr. Richard Zelman, MD is a cardiologist in Forestdale, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Tennessee, and Texas. He is affiliated with Falmouth Hospital and Cape Cod Hospital.
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1986 - 1989- Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
The University of Texas Health Science Center at San AntonioClass of 1983
Certifications & Licensure
FL State Medical License 2022 - 2026
HI State Medical License 2023 - 2026
TX State Medical License 2024 - 2026
VI State Medical License 2023 - 2026
MA State Medical License 1986 - 2025
TN State Medical License 2024 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
Clinical Trials
- Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients Start of enrollment: 2012 Jan 01
- ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial Start of enrollment: 2013 Sep 24
- A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 206 citationsRoutine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.Gregg W. Stone, Michel E. Bertrand, Jeffrey W. Moses, E. Magnus Ohman, A. Michael Lincoff
JAMA. 2007-02-14 - 33 citationsFeasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.Jean Francois Dorval, Simon R. Dixon, Richard B. Zelman, Charles J. Davidson, Robert Rudko
International Journal of Cardiology. 2013-06-20 - 3 citationsSurgical versus trans-catheter aortic valve replacement (SAVR vs TAVR) in patients with aortic stenosis: Experience in a community hospital.Tomer Ziv-Baran, Richard B. Zelman, Philip Dombrowski, Amber E. Schaub, Rephael Mohr
Medicine. 2019-11-01
Press Mentions
An “Attractive Alternative” for AFib PatientsMarch 15th, 2017
Professional Memberships
- Member
